Correlation Between Kura Oncology and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and AnaptysBio, you can compare the effects of market volatilities on Kura Oncology and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and AnaptysBio.

Diversification Opportunities for Kura Oncology and AnaptysBio

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kura and AnaptysBio is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Kura Oncology i.e., Kura Oncology and AnaptysBio go up and down completely randomly.

Pair Corralation between Kura Oncology and AnaptysBio

Given the investment horizon of 90 days Kura Oncology is expected to under-perform the AnaptysBio. But the stock apears to be less risky and, when comparing its historical volatility, Kura Oncology is 1.02 times less risky than AnaptysBio. The stock trades about -0.15 of its potential returns per unit of risk. The AnaptysBio is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest  3,677  in AnaptysBio on August 28, 2024 and sell it today you would lose (1,267) from holding AnaptysBio or give up 34.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kura Oncology  vs.  AnaptysBio

 Performance 
       Timeline  
Kura Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Kura Oncology and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kura Oncology and AnaptysBio

The main advantage of trading using opposite Kura Oncology and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Kura Oncology and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum